BUFFALO, N.Y. — One class of drugs that has shown promise in treating diseases ranging from lung cancer to COVID-19 are targeted covalent inhibitors (TCIs). These small molecule drugs form covalent ...
Senescent cells walk a tightrope, risking cell death with high levels of iron and other damaging agents, but compensating for this by overproducing a protective protein, GPX4, which staves off death.
A paper titled "Functional implications of unusual NOS and SONOS covalent linkages found in proteins," by Matthew D. Lloyd, Kyle S. Gregory, and K. Ravi Acharya, from the University of Bath Department ...
Hosted on MSN
How chemists are rethinking chemical bonds
From the salt in your kitchen to cutting-edge thermoelectrics, chemical bonding shapes the materials we rely on every day. Researchers are now uncovering how tweaking these bonds can unlock new ...
The Chemical Nomenclature STEM Certificate is a self-guided program that provides guidance on rules related to naming in chemistry, including: binary compounds, Types I & II ionic compounds, ...
Novartis is serving up $60 million to partner with Matchpoint Therapeutics in hopes of getting an oral covalent inhibitor over the line for inflammatory diseases that have been historically difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results